CASTLE BIOSCIENCES INC - Common Stock (CSTL)

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / Common Stock
Shares outstanding
29,328,179
Total 13F shares
21,906,465
Share change
-782,258
Total reported value
$571,186,085
Put/Call ratio
0.09%
Price per share
$26.08
Number of holders
152
Value change
-$14,799,148
Number of buys
80
Number of sells
59

Institutional Holders of CASTLE BIOSCIENCES INC - Common Stock (CSTL) as of Q3 2022

As of 30 Sep 2022, CASTLE BIOSCIENCES INC - Common Stock (CSTL) was held by 152 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 21,906,465 shares. The largest 10 holders included WASATCH ADVISORS INC, BlackRock Inc., VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, Bellevue Group AG, Granahan Investment Management, LLC, CITADEL ADVISORS LLC, KORNITZER CAPITAL MANAGEMENT INC /KS, PALISADE CAPITAL MANAGEMENT LLC/NJ, and RTW INVESTMENTS, LP. This page lists 152 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.